97822931 - GENREXVY

Information

• Trademark
• 97822931

• Source

• Serial Number

  97822931

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  March 03, 2023
  a year ago

• Transaction Date

  March 27, 2024
  2 months ago

• Status Date

  January 26, 2024
  4 months ago

• Published for Opposition Date

  November 28, 2023
  6 months ago

• Location Date

  October 26, 2023
  7 months ago

• Status Code

  605

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  HELLMAN, ELI J

• Attorney Docket Number

  315613-20000

  Attorney Name

  Anne H. Peck

  Law Office Assigned Location Code

  L20

• Owners

  • ULTRAGENYX PHARMACEUTICAL INC.

Case File Statements

• GS0051: Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery
• GS0441: Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of metabolic and rare metabolic and genetic diseases and disorders
• GS0421: Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, and metabolic and rare metabolic and genetic diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical, scientific, and medical research, namely, compiling and sharing of patient data for research purposes in the field of metabolic and rare metabolic and genetic diseases and disorders; providing medical and scientific research information in the field of metabolic and rare metabolic and genetic diseases and disorders

Case File Event Statements

• 3/27/2024 - 2 months ago

  18 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 1/26/2024 - 4 months ago

  17 - ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION Type: MAB5

• 1/25/2024 - 4 months ago

  16 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR

• 1/26/2024 - 4 months ago

  15 - ABANDONMENT - AFTER PUBLICATION Type: ABN5

• 12/13/2023 - 5 months ago

  14 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 11/28/2023 - 6 months ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/28/2023 - 6 months ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/8/2023 - 6 months ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/25/2023 - 7 months ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/25/2023 - 7 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/24/2023 - 7 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/24/2023 - 7 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/24/2023 - 8 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/24/2023 - 8 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/24/2023 - 8 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/21/2023 - 8 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/24/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/7/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP